Current Neuro-Oncology

Volume 27 Number 17
20 June 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 17, 20 June

Shiba Y, Aoki K, Ohka F, Deguchi S, Yamaguchi J, Shimizu H, Maeda S, Takido Y, Yamamoto R, Nakamura A, Saito R.
Methionine PET Findings in the Diagnosis of Brain Tumors and Non-Tumorous Mass Lesions: A Single-Center Report on 426 Cases.
AJNR Am J Neuroradiol. 2025 Jun 12:ajnr.A8871. doi: 10.3174/ajnr.A8871. PMID: 40506233. Observational study˰ ˍ

Thompson EM, Ashley DM, Ayasoufi K, Norberg P, Archer G, Buckley ED, Herndon JE 2nd, Walter A, Archambault B, Flahiff C, Jaggers D, Gorski L, Sanchez LA, Congdon K, Hotchkiss K, Cook SL, Moelker E, Vlahovic G, Reap E, Schroeder K, Randazzo D, Desjardins A, Johnson MO, Peters K, Khasraw M, Friedman H, Mitchell DA, Sampson JH, Landi D.
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.
Nat Cancer. 2025 Jun 12. doi: 10.1038/s43018-025-00998-z. PMID: 40506525. Interventional study˰ ˍ

*Lanman T, Densmore I, Nagpal S, Recht L, McGranahan T.
Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy. Neurology. 2025 Jun 13;105(1):e213797. doi: 10.1212/WNL.0000000000213797. PMID: 40513058. Observational study. ˍ

Xu H, Hu X, Wang B, Sun Y, Wang Y, Tang Q, Zhu Q, Song K, Chen H, Chen L, Cheng H, Qin Z.
Comprehensive molecular characterization of adult H3K27M mutated thalamic glioma long-term survivors.
Exp Hematol Oncol. 2025 Jun 13;14(1):84. doi: 10.1186/s40164-025-00677-w. PMID: 40514738. Observational study. ˍ

Baudou É, Ryan JL, Tseng J, Bouffet É, Bartels U, Timmons BW, de Medeiros CB, Mabbott DJ.
Repairing Myelin After Irradiated Pediatric Brain Tumor: A Magnetization Transfer Imaging Analysis.
Pediatr Blood Cancer. 2025 Jun 14:e31838. doi: 10.1002/pbc.31838. PMID: 40515500. Observational study. ˍ

Cardenas-Romero S, Saderi N, Ramirez-Plascencia OD, Baez-Ruiz A, Flores-Sandoval O, Briones CE, Salgado-Delgado RC.
Melatonin Prevents Tumor Growth: The Role of Genes Controlling the Circadian Clock, the Cell Cycle, and Angiogenesis.
J Pineal Res. 2025 Jun 15;77(4):e70064. doi: 10.1111/jpi.70064. PMID: 40518693. Laboratory investigation. ˍ

Crompton DJ, Kern S, Bogan A, Do B, Vora S, Quinones-Hinojosa A, Burns T, Sherman W, Sener UT, Porter AB, Brown P, Laack N, Story MD, Peterson J, Breen WG, Trifiletti DM.
Tumor treating fields utilization and efficacy for glioblastoma at a large multicenter academic practice.
J Clin Neurosci. 2025 Jun 16;138:111395. doi: 10.1016/j.jocn.2025.111395? PMID: 40527221. Observational study˰ ˍ

Liu X, Wang X, Yan P, Zong D, Guo W, He X.
Treatment of a newly diagnosed glioblastoma harboring MET amplification with vebreltinib in combination with radiotherapy: a case report.
Discov Oncol. 2025 Jun 17;16(1):1133. doi: 10.1007/s12672-025-02979-1. PMID: 40526245. Case report. ˍ

Lopez JS, Haefliger S, Plummer R, Clement PM, Jeffry Evans TR, Läubli H, Roth P, Kristeleit R, Brazil L, Tabatabai G, Wick A, Wunderlich B, Beebe K, Eisner JR, Lane H, Engelhardt M, Kaindl T, Hau P, Hundsberger T, Steinbach J.
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma.
Cell Rep Med. 2025 Jun 17;6(6):102165. doi: 10.1016/j.xcrm.2025.102165. PMID: 40532659. Interventional study. ˍ

Ruijters VJ, Snijders TJ, van der Pol JAJ, van de Giessen EM, Niers JM, Broen MPG, Anten MM, van Zanten SEMV, Geurts M, Arens AIJ, Henssen DJHA, Gijtenbeek JM, van der Meulen M, Sijben AEJ, Ghariq E, Vos MJ, Tim J, Bosma IB, Stormezand GN, Frederix GWJ, Dankbaar JW, Robe PA, Verhoeff JJC, de Vos FYFL, Lam MGEH, Ten Ham RMT, Tolboom N.
[¹⁸F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.
Trials. 2025 Jun 17;26(1):208. doi: 10.1186/s13063-025-08921-8. PMID: 40528226. Interventional study protocol. ˍ

Yap TA, Rixe O, Baldini C, Brown-Glaberman U, Efuni S, Hong DS, Massard C, Muzaffar J, Varga A, Yilmaz E, Ikawa Y, Shiue LH, Liu Y, Hruska MW, Zhao H, Tokunaga A, Sahebjam S.
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors.
Cancer. 2025 Jun 19;131(13):e35939. doi: 10.1002/cncr.35939. PMID: 40536766. Interventional study. ˍ

**Kanayama S, Watanabe K, Tanaka M, Takita J, Todo T.
Epithelial-Mesenchymal Transition and Genetically Driven Early Tumor Seedings in Extraneural Metastasis of Glioblastoma.
Cancer Sci. 2025 Jun 20. doi: 10.1111/cas.70126. PMID: 40539386. Case report. ˍ

Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S.
Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005.
Clin Cancer Res. 2025 Jun 20. doi: 10.1158/1078-0432.CCR-24-3721. PMID: 40540301. Interventional study˰ ˍ